US Drug Enforcement Administration DEA seeks to establish more pathways for prescription of controlled substances in limited quantities via telehealth without initial in-person medical exam. This practice is allowed during COVID-19 public health emergency ending May 11th.
On February 24, 2023, the US Drug Enforcement Administration (DEA) issued two proposed rules (the Telemedicine Controlled Substance Proposed Rule and the Telemedicine Buprenorphine.